Critically, our preliminary study from Ph+ ALL patient cohorts revealed that low expression of P2RX1 is significantly associated with inferior prognosis (22), suggesting that P2RX1 may function as a tumor suppressor in this disease. This evidence concerns the gene P2RX1 and neoplasm.